Blog

- Andrew Celentano

Arthrex Achieves First Case with NanoNeedle™ Scope 2.0

NAPLES, Fla., Sept. 23, 2025 /PRNewswire/ — Arthrex, a global leader in minimally invasive surgical technology, announced the launch of NanoNeedle™ scope 2.0, the latest version of the company’s minimally invasive imaging platform. The technology was recently used for the first time in a clinical case by Kyle Anderson, MD, at Anderson Sports Medicine in Bingham Farms, Michigan.

Read More »

Noul Secures FDA Registration for Cervical Cancer Diagnostic Cartridge

YONGIN, South Korea, Sept. 23, 2025 /PRNewswire/ — Noul Co., Ltd. (CEO: David Lim), a medical AI company specializing in blood and cancer diagnostics, announced that FDA registration has been completed for its cervical cancer diagnostic cartridge miLab™ Cartridge CER and clearing agent SafeFix™ CER, both core components of the company’s cervical cancer diagnostic solution miLab™ CER.

Read More »